1 min.
Mario Sturion, Johnson & Johnson Innovative Medicine Italia, amongst the first signatories of the Manifesto
RomeCup is important for the entire economy, to develop artificial intelligence and robotics to benefit the future of humanity. As we work in health, our primary concern is accelerating the development of new drugs and custom-tailored medication to improve patient experience.
Mario Sturion, Managing Director Johnson & Johnson Innovative Medicine Italia, was amongst the first signatories of the Manifesto for Collective Action on Artificial Intelligence and Robotics, an invitation to form a strategic alliance and work together on 10 concrete actions that will drive development focusing on the skills and work of young people, as well as a commitment to block any further inequality, exclusion, and poverty.
